Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
The Journal of the American Osteopathic Association
|
October 27, 2005
Management of osteoarthritic knee pain
Bernard R Rubin
The Journal of the American Osteopathic Association
|
November 29, 2007
Managing osteoarthritic knee pain
Melanie C Barron, Bernard R Rubin
The Journal of the American Osteopathic Association
|
May 8, 2003
An analysis of osteoporosis-related hip fractures using hospital discharge data
Bernard R Rubin, Antonio A René, Douglas A Mains, et al.
Current Medical Research and Opinion
|
June 26, 2007
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout
Sandra Navarra, Bernard R Rubin, Qinfen Yu, et al.
Current Medical Research and Opinion
|
July 13, 2006
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies
Steven S Smugar, Thomas J Schnitzer, Arthur L Weaver, et al.
Arthritis and Rheumatism
|
February 12, 2004
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial
Bernard R Rubin, Robert Burton, Sandra Navarra, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
The Journal of the American Osteopathic Association
|
October 27, 2005
Management of osteoarthritic knee pain
Bernard R Rubin
The Journal of the American Osteopathic Association
|
November 29, 2007
Managing osteoarthritic knee pain
Melanie C Barron, Bernard R Rubin
The Journal of the American Osteopathic Association
|
May 8, 2003
An analysis of osteoporosis-related hip fractures using hospital discharge data
Bernard R Rubin, Antonio A René, Douglas A Mains, et al.
Current Medical Research and Opinion
|
June 26, 2007
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout
Sandra Navarra, Bernard R Rubin, Qinfen Yu, et al.
Current Medical Research and Opinion
|
July 13, 2006
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies
Steven S Smugar, Thomas J Schnitzer, Arthur L Weaver, et al.
Arthritis and Rheumatism
|
February 12, 2004
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial
Bernard R Rubin, Robert Burton, Sandra Navarra, et al.
Page
of 1